Jemma Dunn

Jemma Dunn is an accomplished scientist with expertise in molecular platform development and neuro-oncology. Currently serving as Principal Scientist at SENISCA since March 2021, Jemma previously held the position of Senior Research Scientist at the same organization. Prior to that, Jemma worked as a Postdoctoral Researcher at the University of Plymouth from November 2018 to March 2021, focusing on projects related to PhD research, particularly investigating the potential of kinase NEK9 as a therapeutic target in meningiomas. Jemma Dunn holds a PhD in Neuro-oncology from the University of Plymouth and a BSc (Hons) in Biology from the University of the West of England.